Locations:

Research

June 11, 2018/Cancer/Research

Multigene Assay Holds Prognostic Promise for Renal Cell Carcinoma

Identifying low and high risk of recurrence

June 5, 2018/Cancer/Research

Higher Blood-Based Tumor Burden Predicts Better Response to Immunotherapy in Metastatic NSCLC Patients

Results based on early data from clinical trial

June 4, 2018/Cancer/Research

CCGA Substudy Demonstrates Project’s Potential to Map Cancer Genetics

Early results presented at ASCO 2018

June 4, 2018/Cancer/Research

Advanced Melanoma Survival and Costs Differ in Treatment Combo and Sequence Comparison

One sequence/combo = longer survival, lower costs

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

June 3, 2018/Cancer/Research

IMmotion151 Reports Encouraging Results

New mRCC medication regimen effective and well tolerated

June 2, 2018/Cancer/Research

Immunotherapy Vaccine Improves Survival Rates in Patients with Glioblastoma

Drug stimulates an immune response to survivin

Metastatic melanoma cells. Image source: National Cancer Institute

June 2, 2018/Cancer/Research

Familial Melanoma Diagnosis Can Signal Higher Risk for Other Cancers

Many genetic alterations were related to other malignancies

June 2, 2018/Cancer/Research

T-DM1 + Neratinib’s Safety and Efficacy in Women with Metastatic HER2+ Breast Cancer

Phase 1b trial shows good response rate

June 1, 2018/Cancer/Research

ALLELE: Guiding Glioblastoma Treatment with Tumor Genetics

Individual tumor DNA may be key

May 31, 2018/Cancer/Research

Getting Advanced Stage Cancer Patients on TRK with Targeted Therapy

Response to larotrectinib “almost miraculous”

BackPage 22 of 42Next